Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 6NETWORK 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2CNS 1

Conditions

Sarcoma 1Recurrent High Grade Meningioma 1Chondrosarcoma, Mesenchymal 1

Interventions

Specimen Handling 68Magnetic Resonance Spectroscopy 53Cyclophosphamide 45Vincristine 38Radiotherapy 31Radiation 31Cisplatin 31Carboplatin 30Dexamethasone 27Etoposide 26Doxorubicin 25Biopsy 25daratumumab 17Radiotherapy, Intensity-Modulated 17Prednisone 17Platinum 16Paclitaxel 16Irinotecan 16Cytarabine 16durvalumab 15Gemcitabine 151,2-diaminocyclohexaneplatinum II citrate 15Observation 14Methotrexate 14Leucovorin 14Docetaxel 14Lenalidomide 13X-Rays 12Watchful Waiting 12Rituximab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Trabectedin × 1 year × Clear all
NCT04305548 2026-03-27

ISG-MCS

Italian Sarcoma Group

Phase 2 Recruiting
16 enrolled
Sarcoma

Chondrosarcoma, Mesenchymal

NCT04383119 2026-03-25

ISG-ARTICLE

Italian Sarcoma Group

Phase 2 Recruiting
100 enrolled
Sarcoma

Sarcoma

NCT02234050 2025-07-10

Trabectedin for Recurrent Grade II/III Meningioma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
90 enrolled 18 charts
CNS

Recurrent High Grade Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡